TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

'Jinko Ayurved aur Vedo ka gyaan nahi…': Patanjali's ad against Dabur Chyawanprash comes under HC fire

The Delhi High Court has restrained Patanjali from running the ad
Photo for representational purpose only. Reuters file

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

The Delhi High Court on Thursday restrained Patanjali from running ‘disparaging’ advertisements against Dabur Chyawanprash and questioning the authenticity of non-Patanjali ‘chyawanprash’ products.

Advertisement

Justice Mini Pushkarna allowed Dabur’s interim injunction plea which alleged “Patanjali Special Chyawanprash” was “disparaging DABUR Chyawanprash specifically” and chyawanprash in general, by claiming that “no other manufacturer has the knowledge to prepare chyawanprash”.

Advertisement

The high court posted the matter for further hearing on July 14.

“Jinko Ayurved aur Vedo ka gyaan nahi, Charak, Sushrut, Dhanwantari aur Chyawanrishi ke parampara mei ‘original’ Chyawanprash kaise bana payenge?” read the alleged advertisement in question.

“In addition, false and misleading statements made in the advertisements (in respect of an ayurvedic drug/medicine), in disparaging comparison with DABUR Chyawanprash,” the petition claimed.

Advertisement

Dabur objected to specific references in Patanjali's advertisements calling a 40-herb chyawanprash “ordinary”, denoting that all other chyawanprash were "inferior".

The advertisement also made "untrue" claims that all other manufacturers had no knowledge of Ayurvedic texts and the formulae used to prepare chyawanprash, it submitted.

To label other brands as “ordinary” was both misleading and harmful, Dabur submitted.

Maintaining that chyawanprash was a classic Ayurvedic medicine regulated under the Drugs and Cosmetics Act, which mandates adherence to prescribed formulations based on ancient ayurvedic texts, Dabur contended that the ad misled consumers and undermined their confidence in a category of products governed by strict regulatory standards.

Advertisement
Tags :
#AdvertisingDispute#ChyawanprashControversy#HealthSupplements#InterimInjunction#PatanjaliVsDaburAyurvedaDaburDelhiHighCourtLegalBattlePatanjali
Show comments
Advertisement